EIDOS THERAPEUTICS INC's ticker is EIDX and the CUSIP is 28249H104. A total of 79 filers reported holding EIDOS THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,123,000 | +5.1% | 22,234 | -0.7% | 0.00% | 0.0% |
| Q2 2020 | $1,068,000 | -26.2% | 22,400 | -24.2% | 0.00% | -40.0% |
| Q1 2020 | $1,447,000 | -10.9% | 29,540 | +4.4% | 0.01% | 0.0% |
| Q4 2019 | $1,624,000 | +257.7% | 28,301 | +93.7% | 0.01% | +400.0% |
| Q2 2019 | $454,000 | – | 14,609 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,123,630 | $53,563,000 | 20.44% |
| Board of Trustees of The Leland Stanford Junior University | 265,670 | $12,664,000 | 10.90% |
| Opaleye Management Inc. | 315,550 | $14,634,000 | 2.96% |
| RA Capital Management | 2,162,671 | $103,095,000 | 2.01% |
| Cormorant Asset Management, LP | 1,055,302 | $50,306,000 | 1.92% |
| Parkman Healthcare Partners LLC | 41,085 | $1,959,000 | 0.55% |
| Redmile Group, LLC | 593,842 | $28,308,000 | 0.52% |
| Perceptive Advisors | 686,922 | $30,115,000 | 0.49% |
| HighVista Strategies LLC | 10,596 | $505,000 | 0.42% |
| Ikarian Capital, LLC | 100,000 | $4,767,000 | 0.38% |